Fwangmun Haggai

Co-leads recruitment for IESE's first Master in Finance and runs MiM and MiF recruitment fairs in five countries. Leads the organization of the second edition of IESE's AI Intelligence Lab, a 10-week Claude workshop series.

Segmented recruitment regions and rebuilt outreach in Salesforce CRM, lifting qualified leads 150% and conversion 120%. Built a sales force effectiveness system on Sales Navigator, LinkedIn Recruiter, and CRM reporting for a 30+ nationality pipeline.

Led the internal workstream on indication selection and market entry for a pharma client's rare disease portfolio, including oncology, across Euro5, Japan, Benelux, and the Nordics, shaping recommendations around each country's regulatory framework.

Owned regional revenue and strategy, holding the $1.3M base while opening new markets worth $400K. Chaired the Retail/Bloom software improvement project, cutting partner complaints 80% in 4 months.

Ran business development that grew revenue 60% against a 35% target by end of Q3 2020. Closed 2 deals worth $70K, oversaw negotiation of a $2.5M joint venture with Nigeria's National Agency for the Control of AIDS (NACA), and led pricing in the cluster's largest client and supplier negotiations.

Grew territory revenue from $40K to $1.3M a year across 12 hospitals, 80% above target. Priced 2,500+ SKUs line by line to win a 3-hospital group in 20% of the usual negotiation time; it became mPharma Nigeria's 2nd largest key account at $1M a year.

Set selling prices for the drug portfolio and ran the supply chain for 12 pharmacy partners, lifting fulfilment from the 60% company average to 80% and revenue 40% ($600K). Set up a 2-year, $500K partnership with a Tier 1 healthcare broker, cutting the cash conversion cycle by 66%.

Positioned lower-cost Proximexa and Clavulin next to Zinnat and Augmentin for patients priced out of the originals, seeding each pair with doctors, pharmacists and buyers; GSK's antibiotic market share in Port Harcourt rose from 45% to 60% in 2 years. Managed $2.5M in enterprise contracts with public bodies, tertiary hospitals, Shell and Chevron, setting pricing across 3 tiers.

Reviewed medication records weekly with JUTH's multidisciplinary care team, contributing to a 15% cut in hospital stays. Introduced patient follow-up and pharmaceutical care records in community practice, raising repeat customers 10% in 3 months and annual revenue 15% from $1.2M.

MBA from IESE Business School, ranked #4 in the world by the FT Global MBA Ranking 2026.

Bachelor of Pharmacy degree from the University of Jos, with licensure as a pharmacist.